Credit Agricole’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $31.2M | Buy |
80,664
+58,192
| +259% | +$21.6M | 0.06% | 240 |
|
|
2026
Q1 | $6.58M | Sell |
22,472
-67,250
| -75% | -$22.1M | 0.02% | 507 |
|
|
2025
Q4 | $31.5M | Buy |
89,722
+6,089
| +7% | +$2.06M | 0.07% | 203 |
|
|
2025
Q3 | $27M | Buy |
+83,633
| New | +$26M | 0.07% | 196 |
|
|
2025
Q1 | $37M | Buy |
85,118
+35,162
| +70% | +$14.1M | 0.12% | 142 |
|
|
2024
Q4 | $18.4M | Sell |
49,956
-14,168
| -22% | -$5.93M | 0.05% | 251 |
|
|
2024
Q3 | $33.3M | Sell |
64,124
-8,823
| -12% | -$4.71M | 0.14% | 113 |
|
|
2024
Q2 | $39.5M | Buy |
72,947
+58,409
| +402% | +$30.9M | 0.21% | 88 |
|
|
2024
Q1 | $7.64M | Buy |
14,538
+7,808
| +116% | +$3.88M | 0.08% | 202 |
|
|
2023
Q4 | $3.17M | Buy |
6,730
+4,345
| +182% | +$2.01M | 0.04% | 258 |
|
|
2023
Q3 | $1.04M | Buy |
2,385
+2,236
| +1,501% | +$1.01M | 0.02% | 341 |
|
|
2023
Q2 | $66.2K | Buy |
149
+73
| +96% | +$33.7K | ﹤0.01% | 510 |
|
|
2023
Q1 | $34.9K | Hold |
76
| – | – | ﹤0.01% | 528 |
|
|
2022
Q4 | $39K | Buy |
+76
| New | +$38.6K | ﹤0.01% | 543 |
|
|
2021
Q2 | – | Sell |
-200
| Closed | -$72K | – | 690 |
|
|
2021
Q1 | $72K | Hold |
200
| – | – | ﹤0.01% | 416 |
|
|
2020
Q4 | $64K | Hold |
200
| – | – | ﹤0.01% | 374 |
|
|
2020
Q3 | $54K | Hold |
200
| – | – | ﹤0.01% | 360 |
|
|
2020
Q2 | $53K | Hold |
200
| – | – | ﹤0.01% | 326 |
|
|
2020
Q1 | $45K | Hold |
200
| – | – | ﹤0.01% | 324 |
|
|
2019
Q4 | $60K | Hold |
200
| – | – | ﹤0.01% | 304 |
|
|
2019
Q3 | $48K | Buy |
+200
| New | +$54.8K | ﹤0.01% | 379 |
|
|
2017
Q4 | – | Sell |
-85,050
| Closed | -$16.1M | – | 586 |
|
|
2017
Q3 | $16.1M | Buy |
85,050
+467
| +0.6% | +$88.9K | 0.06% | 349 |
|
|
2017
Q2 | $15.9M | Sell |
84,583
-6,664
| -7% | -$1.2M | 0.05% | 370 |
|
|
2017
Q1 | $15.1M | Sell |
91,247
-266,718
| -75% | -$42.4M | 0.05% | 431 |
|
|
2016
Q4 | $51.5M | Buy |
357,965
+22,891
| +7% | +$3.07M | 0.17% | 156 |
|
|
2016
Q3 | $42M | Sell |
335,074
-258
| -0.1% | -$33.3K | 0.14% | 188 |
|
|
2016
Q2 | $44M | Sell |
335,332
-54,401
| -14% | -$7.44M | 0.17% | 148 |
|
|
2016
Q1 | $54.2M | Sell |
389,733
-185,060
| -32% | -$24.7M | 0.26% | 98 |
|
|
2015
Q4 | $80.2M | Buy |
574,793
+210,718
| +58% | +$29M | 0.37% | 57 |
|
|
2015
Q3 | $51M | Buy |
364,075
+214,551
| +143% | +$32.2M | 0.25% | 79 |
|
|
2015
Q2 | $24.5M | Sell |
149,524
-36,744
| -20% | -$5.87M | 0.12% | 199 |
|
|
2015
Q1 | $28.8M | Sell |
186,268
-72,159
| -28% | -$10.3M | 0.13% | 180 |
|
|
2014
Q4 | $32.4M | Sell |
258,427
-1,755
| -0.7% | -$217K | 0.14% | 167 |
|
|
2014
Q3 | $31.1M | Sell |
260,182
-192,742
| -43% | -$22.1M | 0.13% | 186 |
|
|
2014
Q2 | $48.7M | Sell |
452,924
-301,033
| -40% | -$31M | 0.21% | 114 |
|
|
2014
Q1 | $75.1M | Buy |
753,957
+107,230
| +17% | +$9.7M | 0.3% | 78 |
|
|
2013
Q4 | $59.8M | Buy |
646,727
+41,441
| +7% | +$3.68M | 0.25% | 99 |
|
|
2013
Q3 | $50.6M | Buy |
+605,286
| New | +$51.9M | 0.22% | 111 |
|
Other funds holding ELV
Credit Agricole's ELV Position: Q2 2026 in Review
Credit Agricole increased its Elevance Health (ELV) stake by 259% in Q2 2026, buying an estimated $21.6M and bringing the position to 80,664 shares worth $31.2M. The position accounts for 0.06% of the portfolio, ranked #240.
Credit Agricole first reported a position in ELV in Q3 2013 and has held it in 38 quarters since. The position peaked at $80.2M in Q4 2015. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Credit Agricole held 80,664 shares of Elevance Health worth $31.2M as of Q2 2026.
- Credit Agricole bought 58,192 Elevance Health shares in Q2 2026, an estimated $21.6M.
- Elevance Health made up 0.06% of Credit Agricole's portfolio in Q2 2026, its #240 holding.
- Credit Agricole first reported a position in Elevance Health in Q3 2013 and has held it in 38 quarters since.
- Credit Agricole's Elevance Health position peaked at $80.2M in Q4 2015.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.